CZ254294A3 - Peptides, process of their preparation, their use in the preparation of pharmaceutical preparations and pharmaceutical compositions containing thereof - Google Patents

Peptides, process of their preparation, their use in the preparation of pharmaceutical preparations and pharmaceutical compositions containing thereof Download PDF

Info

Publication number
CZ254294A3
CZ254294A3 CZ942542A CZ254294A CZ254294A3 CZ 254294 A3 CZ254294 A3 CZ 254294A3 CZ 942542 A CZ942542 A CZ 942542A CZ 254294 A CZ254294 A CZ 254294A CZ 254294 A3 CZ254294 A3 CZ 254294A3
Authority
CZ
Czechia
Prior art keywords
substituents
peptides
formula
nhco
group
Prior art date
Application number
CZ942542A
Other languages
Czech (cs)
English (en)
Inventor
Vincenzo Pavone
Angelina Lombardi
Carlo Pedone
Carlo Alberto Maggi
Laura Quartara
Original Assignee
Menarini Farma Ind
Guidotti & C Spa Labor
Malesci Sas
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Menarini Farma Ind, Guidotti & C Spa Labor, Malesci Sas filed Critical Menarini Farma Ind
Publication of CZ254294A3 publication Critical patent/CZ254294A3/cs

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/50—Cyclic peptides containing at least one abnormal peptide link
    • C07K7/54—Cyclic peptides containing at least one abnormal peptide link with at least one abnormal peptide link in the ring
    • C07K7/56—Cyclic peptides containing at least one abnormal peptide link with at least one abnormal peptide link in the ring the cyclisation not occurring through 2,4-diamino-butanoic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/02—Peptides of undefined number of amino acids; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/06—Antimigraine agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/22—Tachykinins, e.g. Eledoisins, Substance P; Related peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Pain & Pain Management (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Immunology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Pulmonology (AREA)
  • Rheumatology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Peptides Or Proteins (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
CZ942542A 1992-04-15 1993-04-13 Peptides, process of their preparation, their use in the preparation of pharmaceutical preparations and pharmaceutical compositions containing thereof CZ254294A3 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ITFI920089A IT1262902B (it) 1992-04-15 1992-04-15 Composti triciclici antagonisti delle tachichinine, loro preparazione e loro uso in composizioni farmaceutiche.

Publications (1)

Publication Number Publication Date
CZ254294A3 true CZ254294A3 (en) 1995-07-12

Family

ID=11350056

Family Applications (1)

Application Number Title Priority Date Filing Date
CZ942542A CZ254294A3 (en) 1992-04-15 1993-04-13 Peptides, process of their preparation, their use in the preparation of pharmaceutical preparations and pharmaceutical compositions containing thereof

Country Status (28)

Country Link
EP (1) EP0636146B1 (enExample)
JP (1) JPH08500331A (enExample)
KR (1) KR950700935A (enExample)
CN (1) CN1039126C (enExample)
AT (1) ATE156135T1 (enExample)
AU (1) AU671118B2 (enExample)
BG (1) BG99110A (enExample)
BR (1) BR9306248A (enExample)
CA (1) CA2118253A1 (enExample)
CZ (1) CZ254294A3 (enExample)
DE (1) DE69312698T2 (enExample)
DK (1) DK0636146T3 (enExample)
ES (1) ES2105265T3 (enExample)
FI (1) FI944838A7 (enExample)
GR (1) GR3024348T3 (enExample)
HR (1) HRP930814A2 (enExample)
HU (1) HUT70189A (enExample)
IL (1) IL105381A (enExample)
IT (1) IT1262902B (enExample)
MX (1) MX9302161A (enExample)
NO (1) NO943861L (enExample)
NZ (1) NZ251969A (enExample)
RO (1) RO112872B1 (enExample)
RU (1) RU94045890A (enExample)
SK (1) SK124294A3 (enExample)
TW (1) TW234718B (enExample)
WO (1) WO1993021227A1 (enExample)
ZA (1) ZA932644B (enExample)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1277835B1 (it) * 1995-03-13 1997-11-12 Menarini Farma Ind Composti biciclici, loro preparazione ed uso in composizioni farmaceutiche
IT1283171B1 (it) * 1996-03-01 1998-04-16 Interdipartimentale Di Ricerca Composti solubili antagonisti delle tachichinine loro preparazione e loro uso in composizioni farmaceutiche
IT1291776B1 (it) 1997-02-07 1999-01-21 Menarini Ricerche Spa Composti monociclici a quattro residui bifunzionali, aventi azione nk-2 antagonista
IT1307809B1 (it) 1999-10-21 2001-11-19 Menarini Ricerche Spa Composti monociclici basici ad azione nk-2 antagonista, processi difabbricazione e formulazioni che li contengono.
EP1297826A1 (en) * 2001-09-27 2003-04-02 Menarini Ricerche S.p.A. Nasal pharmaceutical compositions containing a NK-2 antagonist

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8807246D0 (en) * 1988-03-25 1988-04-27 Merck Sharp & Dohme Therapeutic agents
DE3915361A1 (de) * 1989-05-11 1990-11-15 Merck Patent Gmbh Cyclopeptide

Also Published As

Publication number Publication date
ITFI920089A0 (it) 1992-04-15
AU671118B2 (en) 1996-08-15
SK124294A3 (en) 1995-07-11
ES2105265T3 (es) 1997-10-16
WO1993021227A1 (en) 1993-10-28
CN1080916A (zh) 1994-01-19
TW234718B (enExample) 1994-11-21
FI944838L (fi) 1994-10-14
GR3024348T3 (en) 1997-11-28
MX9302161A (es) 1994-05-31
RU94045890A (ru) 1996-09-10
RO112872B1 (ro) 1998-01-30
IT1262902B (it) 1996-07-22
DE69312698T2 (de) 1997-12-04
AU4039593A (en) 1993-11-18
ZA932644B (en) 1993-10-22
NO943861D0 (no) 1994-10-13
CN1039126C (zh) 1998-07-15
HU9402977D0 (en) 1995-02-28
NZ251969A (en) 1997-12-19
IL105381A (en) 1998-02-22
HUT70189A (en) 1995-09-28
FI944838A0 (fi) 1994-10-14
DK0636146T3 (da) 1998-02-23
EP0636146B1 (en) 1997-07-30
DE69312698D1 (de) 1997-09-04
EP0636146A1 (en) 1995-02-01
ATE156135T1 (de) 1997-08-15
BG99110A (bg) 1995-09-29
FI944838A7 (fi) 1994-10-14
ITFI920089A1 (it) 1993-10-15
KR950700935A (ko) 1995-02-20
JPH08500331A (ja) 1996-01-16
HRP930814A2 (en) 1996-12-31
NO943861L (no) 1994-10-13
CA2118253A1 (en) 1993-10-28
BR9306248A (pt) 1998-06-23

Similar Documents

Publication Publication Date Title
FI104253B (fi) Menetelmä terapeuttisesti käyttökelpoisten nonapeptidibombesiiniantagonistien valmistamiseksi
KR20010022924A (ko) 페네틸아민 유도체
PT2213680E (pt) Péptidos que possuem uma atividade farmacológica para o tratamento de distúrbios associados à migração de células alteradas, tais como o cancro
EP0794959A1 (en) Amino acids for making betides and methods of screening and making betide libraries
JP3568952B2 (ja) ５位及び６位に修飾アミノアシル残基を有するｌｈｒｈ拮抗薬
US5731285A (en) Tachiquinine antagonist tricyclic compounds, preparation of same and pharmaceutical compositions containing such compounds
CZ254294A3 (en) Peptides, process of their preparation, their use in the preparation of pharmaceutical preparations and pharmaceutical compositions containing thereof
SK281899B6 (sk) Bicyklické peptidy, farmaceutický prostriedok s ich obsahom a ich použitie
HUT63178A (en) Process for producing bombesin antagonist polypeptides
CA2182486C (en) Cyclic neurokinin a antagonists
KR101412119B1 (ko) 생리적 안정성을 증가시킨 ｐａｒ―2 활성화 펩타이드 및 이를 함유하는 약제학적 조성물
CA2405724C (en) Substance p analogs for the treatment of cancer
JP2010150253A (ja) 肝癌を治療するための薬剤
US5786447A (en) Opioid peptide analogs
EP0606222A1 (en) Cyclic hexapeptides as tachyquinin antagonists, their preparation and pharmaceutical compositions thereof
AU700904C (en) Amino acids for making betides and methods of screening and making betide libraries
WO2011127624A1 (zh) 抗hiv肽